Home / 2022 / June / 01

Daily Archives: June 1, 2022

D’Addario Designates June 6, 2022, as #WorldStringChangeDay

Celebrate World String Change Day!

The world’s leading string company holds their inaugural string-themed holiday on June 6th

FARMINGDALE, N.Y., June 01, 2022 (GLOBE NEWSWIRE) — D’Addario, the world’s premier guitar string maker, is proud to announce the inaugural celebration of #WorldStringChangeDay on Monday, June 6, 2022.

As the world leader in guitar string innovation and quality, D’Addario is inviting musicians around the globe to celebrate the ritual and reward of caring for their instrument with a fresh set of strings.

“There’s nothing better than the feel and tone of fresh strings,” says acclaimed Brazilian Guitarist and Technician Lari Basilio. “It makes the playability smoother, the tone more vibrant, and inspires you again!”

Players on social media will be encouraged to show off how their instrument looks, plays, and sounds with fresh strings and dive into their own preferences and string-changing techniques.

Throughout the week leading up to #WorldStringChangeDay, Guitarists, Bassists, Ukulele, and Mandolin players across D’Addario’s worldwide artist roster, like Herman Li, Evan Taucher, Lari Basilio, JB Brubaker, Casper Esman, Mark Tremonti, and more will be sharing content around the importance of changing strings and maintaining your instrument.

“D’Addario strings have always been my go-to,” says Grammy-Nominated guitarist Michael Kiwanuka. “There’s just something about them that makes my guitar sound and feel the way it should. They’re the first step to achieving a great tone. With a fresh set of strings, I’m always inspired to pick up my guitar and play.”

As part of the new holiday, D’Addario will be hosting a giveaway via social media where players can post a story of them changing their strings for a chance to win a set of strings of their choice.

Musicians are encouraged to post on their social media pages using #WorldStringChangeDay to be a part of the conversation and have a chance to have their posts shared by D’Addario & Co.

D’Addario’s history of manufacturing guitar strings dates back to the 1600s in Salle, Italy. As part of their commitment to vertical integration, D’Addario manufactures more than 700,000 strings a day in Farmingdale, New York, made possible by their own in-house wire mill.

To learn more about how you can get involved, please visit: https://ddar.io/WSCD.PR

D’Addario & Company, Inc.

D’Addario is the world’s largest manufacturer of musical instrument accessories, marketed under several product brands: D’Addario Fretted, D’Addario Orchestral, D’Addario Woodwinds, Promark Drumsticks, Evans Drumheads, and Puresound Snare Wires. A family-owned and operated business with roots dating back to the 17th century, D’Addario now has over 1,100 employees worldwide, and manufactures 95% of its products in the U.S. while utilizing Toyota’s Lean manufacturing principles. D’Addario musical accessories are distributed in 120 countries, serve more than 3,300 U.S. retailers, all major e-commerce sites, and are the preferred choice of musicians worldwide such as, Keith Urban, Zac Brown, Brandi Carlile, Dave Matthews, Gary Clark Jr., Chris Thile, Ry Cooder, Joe Satriani, Julia Fischer, Anderson .Paak, Kacey Musgraves and more.

The D’Addario Foundation believes in the power of music to unlock creativity, boost self-confidence, and enhance academics. D’Addario also reinforces its role as a social and environmental leader with initiatives such as Playback and PlayPlantPreserve.

Media Contact – D’Addario & Co, Inc.
Natalie Morrison (natalie.morrison@daddario.com)

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/94e60972-3b85-46fd-aa13-11bf42c8927d

Top Go-To-Market Leaders Join Sumo Logic

Sumo Logic welcomes sales, channel and operations leaders to help capture large market opportunities and further deliver growth and scale

REDWOOD CITY, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Sumo Logic (NASDAQ: SUMO), the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced the appointment of four new senior leaders. This team is poised to help drive focus and ensure efficient global growth as Sumo Logic helps companies of all sizes with digital transformation, cloud migration, and security modernization initiatives.

Sumo Logic welcomes:

  • Zakir Ahmed, Managing Director of APAC and International Market Strategy
  • Steve Doyle, SVP of Global Sales Strategy and Operations
  • Timm Hoyt, SVP of Global Channels and Alliances
  • Russell Rosa, SVP of America Sales

Lynne Doherty, President of Worldwide Field Operations, Sumo Logic: “I’m thrilled to welcome these four extremely talented leaders to the Sumo Logic team. They each bring proven track records and functional success in growing large, high-velocity organizations that will help accelerate our next phase of growth. Sumo Logic is a critical component of customers’ software stacks, and our job is to build on our early platform success to be the clear leader in serving both the security and observability needs of organizations. This new leadership team, along with the deep talent and passion of all of Sumo Logic, gives me great confidence that we can help our customers win.”

Meet the Team
Based in Singapore, Zakir Ahmed joins Sumo Logic as Managing Director of APAC and International Market Strategy. Ahmed will lead the APAC region and provide advisory support for other international geographies.

Ahmed is not a stranger to building business in a hyper-growth SaaS marketplace. He brings significant experience most recently at Kofax, where he was SVP and General Manager for APAC. While there, Ahmed was responsible for driving a new strategic direction and spearheading its transformation while leading the region through rapid growth and expansion into new markets. He brings extensive experience in management, customer acquisition, retention, and sales leadership from a variety of companies, including the NetSuite Business Unit at Oracle, Salesforce.com, TechnologyOne Corp, and Microcell.

Steve Doyle has been named SVP of Global Sales Strategy and Operations and leads a global team spanning from North America to United Kingdom, Australia, and India. Doyle’s team works to implement the structure, standards, consistency, and processes to help accelerate growth as the business scales.

Prior to joining Sumo Logic, Doyle led global strategic initiatives at Cisco. He spent 16 years in a variety of roles, including leading Global Renewals Operations, where he built a global team of more than 50 professionals to support an expanding business. Doyle also led strategy and planning for Cisco Americas, where he led all sales operations functions including compensation, planning, and forecasting.

Timm Hoyt takes the reins in his new role as SVP of Global Channels and Alliances. A technology industry veteran with a track record of delivering robust, product integration and go-to-market partner strategy, Hoyt will focus on driving market leadership by advancing global partnerships for Sumo Logic. Hoyt brings deep international operations and leadership to the team, with more than 20 years of experience from posts at PagerDuty, Druva, Atlantis Computing, Skyera, and Brocade.

At PagerDuty, Hoyt represented the Global Partner and Alliances organization, establishing five key areas of the practice: Cloud Providers, Channels, Ecosystem Alliances, Managed Service Providers, and System Integrators. Similarly at Druva, Hoyt ran the Global Partner and Alliances organization, while under his stewardship, annual recurring revenue accelerated by transforming the route-to-market into a partner-first sales motion that drove growth, predictability, and durability.

Russell Rosa is the SVP of Americas Sales. Rosa will ensure scale throughout North America and drive strategy in emerging markets like Canada and Latin America. Rosa joins Sumo Logic from Cisco, where he held a number of senior sales leadership roles and successfully built, developed and managed high-performing teams. Rosa spent the last five years running U.S. Commercial East, a business unit comprised of small, midsize and Fortune 500 customers. ​​

Rosa also spent time leading the channel organizations at Actifio and VCE where he helped to build channel strategies and the go-to-market model for the respective teams. This included functions such as distribution, developing partner sales teams, and introducing new solutions into the portfolio.

Additional Resources:

About Sumo Logic
Sumo Logic, Inc. (NASDAQ: SUMO) empowers the people who power modern, digital business. Through its SaaS analytics platform, Sumo Logic enables customers to deliver reliable and secure cloud-native applications. The Sumo Logic Continuous Intelligence Platform™ helps practitioners and developers ensure application reliability, secure and protect against modern security threats, and gain insights into their cloud infrastructures. Customers around the world rely on Sumo Logic to get powerful real-time analytics and insights across observability and security solutions for their cloud-native applications. For more information, visit www.sumologic.com.

Sumo Logic is a trademark or registered trademark of Sumo Logic in the United States and in foreign countries. All other company and product names may be trademarks or registered trademarks of their respective owners.

Media Contact
Carmen Harris
Sumo Logic
(650) 414-1584

Jenna Shikoff
RH Strategic

New Chemical Management Essentials Solution Streamlines Safety Data Sheets, Chemical Approvals to Improve Compliance, Safety

Solution incorporates industry best practices for faster time-to-value

Cority, EHS Software

TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — Organizations today face many regulatory and operational challenges when striving to comply with workplace health and safety regulations. Some of the common challenges are hazard communication, chemical management, tracking the lifecycle of a chemical portfolio, and ensuring employees across the organization have easy access to all pertinent hazard information—both present and past. To meet this need and to advance the health and safety of workplaces worldwide, Cority, a leading global enterprise EHS (Environment, Health, and Safety) software provider, announced the availability of its Chemical Management Essentials solution.

Like all of Cority’s Essentials Solutions, this innovative software package provides built-in best practices and standards, enabling faster time-to-value for customers. Cority’s Chemical Management Essentials helps organizations manage chemical data, maintain a library of updated safety data sheets (SDS), and make informed decisions about what materials to bring on-site.

“Reliance on stacks of hard-copy binders that contain data potentially going back decades and across multiple facilities render accurate reporting almost impossible to achieve with any confidence,” said Arten Charles, Cority Solutions Manager. “Our solution takes all of a company’s SDS information and indexes it digitally for at-a-glance visualization and analysis. Since it can grow with a company’s needs, the software is also a great starting point for any organization that does not already have a system in place.”

Chemical Management Essentials can get clients operational in weeks, providing organizations with a user-friendly solution that can be modified as their business changes and grows.

Key benefits of the cloud-based solution include the ability to:

  • Provide access to hazard and chemical information. Ensuring an organization’s workforce has access to readily available information on SDS and critical hazard information is crucial to their ability to safely perform their job functions.
  • Maintain accurate SDS e-binders. Companies can easily collect and access critical chemical information for thousands of locations, run site-specific reports and analyses, compile summary sheets, and produce secondary container labels.
  • Reduce risk. By extending SDS management, Cority’s solution empowers teams to make informed decisions about what chemicals to bring on-site and which ingredients to use in their products. In addition to reducing on-site and in-product risk, Cority’s solution also streamlines the evaluation of chemicals by enabling the easy identification of restricted chemicals and minimizing their risk for penalties.
  • Improve efficiency. Employees can track and search products by trade name, chemical name, or ingredient to save staff time with quick access to important chemical documents. Organizations can also easily generate out-of-the-box reports, worker safety documents, and labels.
  • Stay compliant. From storing and updating SDSs, properly labeling secondary containers, screening and evaluating new materials before bringing them onsite, and communicating hazards, organizations can be sure they are in compliance with standards and regulations including OSHA, GHS, REACH, RoHS, and more.

Chemical Essentials is also part of CorityOne™, the company’s integrated EHS SaaS-based platform, which provides a scalable and seamless path for future growth and consists of a comprehensive suite of solutions for managing environmental, health, safety, sustainability, and quality programs. The responsible business platform enables datasets to be combined from across the organization for realizing improved efficiencies, data-driven decision-making, and more accurate reporting. Building on an organization’s chemical management program, clients can easily unify all their EHS initiatives into a single comprehensive platform to uncover key insights and create a single, accurate, and holistic view of EHS performance.

“What sets us apart is that we provide our customers the ability to evolve and grow their EHS management systems into an integrated solution that spans all EHS operations and compliance categories,” said Amanda Smith, vice president of Solutions Marketing & Enablement. “CorityOne reduces the burden of managing multiple solutions and improves access to information by compiling all of a company’s data in a single digital home.”

Chemical Management Essentials is a standardized version of Cority’s Chemical Management Solutions software, which provides organizations with a more comprehensive, customizable approach to their chemical management infrastructure over time.

“Cority is a huge time saver. It’s a very efficient software process for managing inventories, for managing safety data sheets, for regulatory prescreening. It’s just been very helpful on a day-to-day basis for maintaining our safety data sheets and inventories,” said Mary Magerkurth, environmental, health & safety specialist with Entegris.

Media Contact: Meredith Schweitzer / mschweitzer@66and.co / 347-698-9196


About Cority

Cority gives every employee from the field to the board room the power to make a difference, reducing risks and creating a safer, healthier and more sustainable world. For over 35 years, Cority’s people-first software solutions have been built by EHS and sustainability experts who know the pressures businesses face. Time-tested, scalable, and configurable, CorityOne is the responsible business platform that combines datasets from across the organization to enable improved efficiencies, actionable insights, data-driven decisions, and more accurate reporting on performance. Trusted by over 1300 organizations worldwide, Cority deeply cares about helping people work toward a better future for everyone. To learn more, visit www.cority.com/.

Related Images

Image 1: Cority, EHS Software

This content was issued through the press release distribution service at Newswire.com.



Vision Hydrogen Acquires Advanced Renewable Fuels Development Project

JERSEY CITY, N.J., June 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Vision Hydrogen Corporation (OTCQB: VIHD) (the “Company”) announces that it has acquired a 100% interest in a 14 Ha port development project (the “Project”) for the storage and distribution of low carbon and renewable fuels, including hydrogen carriers such as ammonia, methanol and liquid organics, strategically located in Vlissingen (Flushing) at the mouth of the Westerschelde estuary in the Netherlands.

The Project is well positioned to be the first terminal in Europe with a core focus on the storage of low carbon and renewable fuels (including hydrogen carriers from which clean hydrogen may be produced) for European markets and off-takers providing carbon abatement.

About Evolution Terminals
Evolution Terminals BV (“EVO”) benefits from a long-lease agreement with North Sea Port for the exclusive use of 143,132m2 of sea-front industrial-zoned land in North Sea Port’s Vlissingen location. In development since Q4 2020, the Project is being designed to provide a liquid bulk storage terminal and jetty, giving ships access to purpose-built storage and handling facilities for low carbon and renewable fuels. The advanced pre-development, planning and engineering of the Project greatly advances its maturity and shortens the Company’s development timelines.

EVO is developing up to c. 600,000m3 (3.66 million bbl) of liquid bulk storage capacity, designed to be constructed in phases with a new deep-water jetty featuring a draught potential of up to 17m and capable of receiving seagoing vessels, barges and coasters. The terminal has access to truck and rail tanker loading and unloading infrastructure, for road and railway connections to the main transportation grids and is being designed to meet and exceed all required safety and environmental standards. Sustainable operational practices are central features to the Project, including the provision for shore power supplied from renewable energy sources.

EVO’s storage tanks will accommodate a wide range of bulk liquid products, while retaining the ability to pivot product inventories, future proofing changes in downstream markets. The extensive 14.3 Ha plot also provides future expansion potential, and the Company is developing synergistic relationships with existing industrial tenants within the Port for the provision of local storage capacity and product handling services, as well as international trading houses and other strategic energy industry participants that are focused on hydrogen and hydrogen-related products in support of Europe’s green energy transition.

The Project is in an advanced stage of permitting, with the Company targeting the award of all necessary construction permits by Q1 2023.


The Company’s Swiss subsidiary VisionH2 Holdings AG has acquired EVO from First Finance Europe Ltd. for USD $3.5 million in cash and 1.5 million shares of common stock valued at a price of $5.00 per share. First Finance is controlled by the Company’s Chief Executive Officer. The transaction was considered and approved by a committee comprised of the independent directors of the Company.

About Vision Hydrogen

VisionH2 is a renewable energy company developing storage, handling and production facilities for the commercial, industrial and transportation sectors. VisionH2 is leveraging its proven track-record in site procurement and permitting, accelerating pre-development and integration of infrastructure to store and distribute low-carbon products and fuels including green hydrogen and hydrogen carriers. By establishing and negotiating long-life customer commitments the Company ensures reliable offtake relationships with industry participants seeking to utilize hydrogen and hydrogen carriers as fuel, feedstock, and as a grid balancing & capacitance solution. VisionH2 is committed to providing the lowest carbon solution with the highest yield storage, handling and production services for the European renewable economy and supply chain. VisionH2 is a portfolio company of First Finance, a private equity investment group with offices in Zurich, London and Vancouver www.firstfinance.com.

Vision Hydrogen Corporation/Investor Relations
95 Christopher Columbus Drive, 16th Floor
Jersey City, NJ 07302
551-298-3600 USA

Forward Looking Statements:

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “forecast”, “anticipate,” “believe,” “estimate,” “expect” and “intend,” among others. These forward-looking statements are based on current expectations, and actual results could differ materially. The Company does not undertake an obligation to update or revise any forward-looking statement. The information set forth herein speaks only as of the date hereof.

Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office

U.S. Polo Assn. Launches Global Summer 2022 Collection from Miami Beach

Iconic, Sport-Inspired Brand Celebrates Summer with Vibrant Prints and Neon Accents

U.S. Polo Assn.

WEST PALM BEACH, Fla., June 01, 2022 (GLOBE NEWSWIRE) — U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has launched its iconic, sport-inspired Summer Collection for 2022. The brand’s global photo shoot, which is shared with U.S. Polo Assn. partners around the world, took place in South Florida’s iconic Miami Beach. Visitors flock from around the world to bask in the tropical Miami Beach atmosphere, where the sun meets sand and sea.

Sun, sand, and saltwater along the shores of trendy Miami Beach create the perfect backdrop for U.S. Polo Assn.’s Summer 2022 Collection. This season’s global photo shoot showcases beachside models lounging beside breezy palms and vibrant lifeguard towers, wearing pops of neon and bold tropical prints. The collection also brings colorful polo shirts, shorts, and graphic t-shirts alongside swimwear and essential summer accessories, including bucket hats and trendy handbags.

Consumers in-store and online around the world can look for color blocked brights and timeless resort stripes inspired by the sunlit Miami horizon. U.S. Polo Assn. has given summer style a refresh with an emphasis on breathable, lightweight fabrics to make fun in the sun easy and breezy. Fans of the brand can bask in soft knit tank dresses and preppy cotton shirts to make the most of a sun-kissed summer with U.S. Polo Assn.

“The inspiration for our Summer 2022 Collection comes from the bold color palette of the sunset and sea. Rich colors bring rejuvenating energy to our classic style that’s in step with today’s current trends,” says Brian Kaminer, SVP of Brand and Product Development for the U.S. Polo Assn. brand. “Innovating new fabrics with textural details make our timeless trends fresh for customers to approach the summer in style.”

U.S. Polo Assn. is known for its sport-inspired, classic American style. The brand’s signature red, white, and blue stripe is used in a variety of ways to add an element of surprise to each garment. Each U.S. Polo Assn. collection takes classic designs to a new level with unique styling, high-quality fabrics, and seasonal comfort. The Summer 2022 Collection follows suit with bold and fresh assortments that offer a wide array of options, including USPA Life apparel with sustainable aspects.

“These are exciting times for the U.S. Polo Assn. brand, with new stores opening around the world, and now the launch of our amazing Summer 2022 Collection,” says J. Michael Prince, President and CEO of USPA Global Licensing, which manages the global, multi-billion-dollar U.S. Polo Assn. brand. “Every season the U.S. Polo Assn. Team works to share our authentic connection to the sport of polo with our customers anywhere, anytime they want to shop, while offering an authentic and service-oriented experience.”

About U.S. Polo Assn. and USPA Global Licensing Inc. (USPAGL)

U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the nonprofit governing body for the sport of polo in the United States and one of the oldest sports governing bodies, having been founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through some 1,200 U.S. Polo Assn. retail stores, department stores, sporting goods channels, independent retailers and e-commerce, U.S. Polo Assn. offers apparel for men, women, and children, as well as accessories and footwear in 190 countries worldwide. Ranked the fifth largest sports licensor in License Global magazine’s 2020 list of “Top 150 Global Licensors,” U.S. Polo Assn. is named alongside such iconic sports brands as the National Football League, the National Basketball Association and Major League Baseball. Visit uspoloassnglobal.com.

USPA Global Licensing Inc. (USPAGL) is the for-profit subsidiary of the USPA and its exclusive worldwide licensor. USPAGL manages the global, multi-billion-dollar U.S. Polo Assn. brand and is the steward of the USPA’s intellectual properties, providing the sport with a long-term source of revenue. Through its subsidiary, Global Polo Entertainment (GPE), USPAGL also manages Global Polo TV, the world’s leading digital platform with polo and lifestyle content. In addition, USPAGL partners with ESPN and beIN Sports globally to share the sport of polo broadcasts on television and on-demand to millions of viewers around the world. For more polo content visit globalpolo.com.

Press Release Contact: 

Stacey Kovalsky – Senior Director, Global Communications
Phone +001.561.790.8036 – Email: skovalsky@uspagl.com

Kaela Drake – PR & Communications
CoordinatorPhone +001.561.461.8596 – Email: kdrake@uspagl.com

Related Images

Image 1: U.S. Polo Assn.

U.S. Polo Assn.

This content was issued through the press release distribution service at Newswire.com.


Completion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive Chair

LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) — Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets and Digital Services Group. The acquisition includes Informa’s full portfolio of specialist brands which includes the Citeline suite of products (Trialtrove, Sitetrove, Pharmaprojects) as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope.

Pharma Intelligence will now enter its next phase of growth under new ownership. As announced on February 10, Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. Informa retains a 15% equity interest in the business.

The investors plan to extend the company’s leading position in the $22 billion pharmaceutical data and analytics market by increasing focus and investment in innovation and product development to improve efficiency in the drug development life cycle.

The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. The company’s solutions are used by 3,000 pharmaceutical companies and CROs in their clinical trial design, commercial strategy, and regulatory compliance processes to maximize the likelihood of success of introducing products to market.

Appointment of Executive Chair
Pharma Intelligence is also delighted to announce the appointment of Jay Nadler as Executive Chair, effective immediately. Jay has led and advised leading companies providing data and analytics, software, and technology-enabled services to a number of industry sectors including life sciences for more than 30 years. He is the current Executive Chair of Sagent Lending Technologies, former CEO of Clarivate, former COO of Interactive Data Corporation, and the former President of Information Holdings’ Pharma Business. He has worked closely with Warburg Pincus for more than 20 years as a portfolio company executive, advisor, and Board member, and has also been an advisor to the firm.

Jay Nadler, Executive Chair, Pharma Intelligence, said, “I am honored to join the Board of Pharma Intelligence and look forward to partnering with Ramsey Hashem, the rest of the management team, employees, and customers, as we work together to introduce more efficiency into the drug development lifecycle. As an independent company, with additional focus and investment, Pharma Intelligence will deliver additional value to all industry stakeholders. I am particularly excited about introducing innovative products to the market, such as Citeline Predict, that leverage the company’s unique data sets, deep understanding of customer challenges, and the latest advancements in data science.”

Ramsey Hashem, CEO, Pharma Intelligence, said, “As we join the Warburg Pincus group of companies, our commitment and vision for the future remain steadfast. With Jay Nadler on board as Executive Chair, we will be able to accelerate growth and take advantage of market opportunities and investments like never before. We look forward to working closely with the team at Warburg Pincus and continuing to deliver our world class suite of products and services to our customers that rely on our insights to make strategic business decisions every day.”

Adarsh Sarma, co-head of Europe at Warburg Pincus and Chandler Reedy, Head of Strategic Investments at Warburg Pincus said, “We are delighted that the acquisition is complete, and we can focus our efforts entirely on the next phase of growth. Working closely with Jay Nadler and the management team, we will build on the excellent work already undertaken and use our industry expertise and experience successfully scaling pharma, health tech and B2B information services businesses, to help the company achieve its growth potential.”

David Reis and Amr Kronfol, Managing Directors at Warburg Pincus, said, “This is an exciting time for the business, its employees, and customers, as Pharma Intelligence becomes an independent company able to achieve its full growth potential. We believe Pharma Intelligence is a high-quality, fast-growing company and that with its outstanding people, products and services and our investment, it will play an increasingly important role within the global pharma and healthcare industry.”

About Pharma Intelligence
Pharma Intelligence powers a full suite of analysis products – Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Biomedtracker™, Scrip™, Pink Sheet™ and In Vivo™ – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.

About Warburg Pincus
Warburg Pincus LLC is a leading global growth investor. The firm has more than $80 billion in assets under management. The firm’s active portfolio of more than 245 companies is highly diversified by stage, sector, and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 21 private equity and 2 real estate funds, which have invested more than $103 billion in over 1,025 companies in more than 40 countries. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore. For more information, please visit www.warburgpincus.com. Follow us on LinkedIn.

About Mubadala Investment Company
Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi.

Mubadala’s $284 billion portfolio spans six continents with interests in multiple sectors and asset classes. It leverages its deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates.

For more information about Mubadala Investment Company, please visit: www.mubadala.com

Media Contacts
Pharma Intelligence
Blair Dawson | Vice President, Commercial Development & Launch
919-413-4616 / blair.dawson@informa.com

Warburg Pincus
Jenna Ward | Europe Communications Director
+44 7570844338 / jenna.ward@warburgpincus.com

First CE-IVD marked AI solution for prognostic risk stratification of breast cancer patients.

Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath Breast, is now CE-IVD marked.

Stockholm, Sweden, June 01, 2022 (GLOBE NEWSWIRE) — Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath Breast, is now CE-IVD marked. This paves the way for clinical implementation in the European Union. Based on the analysis of digital histopathology whole slide images, stained with haematoxylin and eosin (H&E) the software provides novel decision support to clinicians and enables precision medicine for more patients.

Stratipath Breast is the first EU regulatory compliant solution for risk stratification of breast cancer using AI-based precision diagnostics to analyse cancer tissue, and enabling identification of patients with increased risk of disease progression.

In contrast to traditional molecular tests, AI-based risk stratification enables faster turnaround times for results, provides new information at the point of diagnosis and reduces the need for expensive molecular testing, allowing for wider use and benefit to more patients.

“Stratipath Breast offers a faster and cheaper alternative to molecular assays, allowing more patients to have access to precision diagnostics. By using Stratipath Breast, clinicians can diagnose with support from prognostic information, while reducing laboratory time and costs,” says Johan Hartman, professor in pathology at Karolinska Institutet, Stockholm, and co-founder of Stratipath.

Histological tumour grade is a strong prognostic indicator of breast cancer. Grading of invasive breast cancer is performed on all invasive breast cancers based on morphological assessment, according to the Nottingham Histologic Grade (NHG), resulting in the low- to high-risk categories NHG 1, 2 or 3. But currently, more than 50% of all breast cancer patients are categorised as of intermediate risk (i.e NHG 2), which provides little clinical utility for treatment decision-making. The consequential over- and undertreatment of patients with early breast cancer has become one of the main challenges for treating physicians, and the clinical decisions are often dependent on expensive molecular assays that are not accessible to the majority of patients.

Using deep learning, Stratipath Breast enables cancer detection and classification of intermediate risk tumours into low- and high-risk groups, based on grade-related tumour morphology. The stratification comes from a rigorous scientific development process and validation using multi-source real-world datasets, comprising histopathology images and associated clinical outcome data.

The system measures risk-associated morphological patterns locally in the image and aggregates this information across the analysed tissue area to establish whether the tumour belongs to the high- or low-risk group. Results from Stratipath Breast provide prognostic information and are intended to be used as a decision support tool, together with other clinical and pathological information.

Stratipath Breast provides an optimal workflow through integration with leading digital pathology solutions. It can also be used on its own, via the Stratipath customer web portal. Access to Stratipath Breast will be provided as a Software as a Service solution, by a subscription or pay as you use model. Not marketed in the USA.

About Stratipath
Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research in AI and precision medicine into clinical use. The company was founded in 2019 by Johan Hartman, M.D., PhD, Mattias Rantalainen, PhD and Fredrik Wetterhall with a mission to radically improve cancer treatment decisions and patient outcomes. Stratipath offers an AI precision diagnostic solution for healthcare and can offer an accelerated path for pharma and biotech companies to identify patients most likely to benefit from novel therapies.


Lars Lengquist
+46 709574782